Difference between revisions of "Raltitrexed (Tomudex)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - "[http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or" to "or")
 
(17 intermediate revisions by 3 users not shown)
Line 1: Line 1:
 
==General information==
 
==General information==
Class/mechanism: Antimetabolite, inhibitor of thymidylate synthase. Not approved by the FDA. Raltitrexed is a quinazoline folate analogue which inhibits thymidylate synthase (TS).  TSis an enzyme involved in the synthesis of thymidine triphosphate (TTP), a nucleotide required
+
Class/mechanism: Antimetabolite, inhibitor of thymidylate synthase. Raltitrexed is a quinazoline folate analog which inhibits thymidylate synthase (TS).  TSis an enzyme involved in the synthesis of thymidine triphosphate (TTP), a nucleotide required exclusively for DNA synthesis. Inhibiting TS causes DNA damage and cell death.<ref name="insert">[https://www.cancercareontario.ca/file/2481/download?token=xvtyZEaB Raltitrexed (Tomudex) package insert]</ref><ref>[[:File:fluorouracil.pdf | Raltitrexed (Tomudex) package insert (locally hosted backup)]]</ref>
exclusively for DNA synthesis. Inhibiting TS causes DNA damage and cell death.<ref name="insert">[https://www.cancercareontario.ca/file/2481/download?token=xvtyZEaB Raltitrexed (Tomudex) package insert]</ref><ref>[[Media:fluorouracil.pdf | Raltitrexed (Tomudex) package insert (locally hosted backup)]]</ref>
 
 
<br>Route: IV
 
<br>Route: IV
 
<br>Extravasation: [[irritant]]
 
<br>Extravasation: [[irritant]]
  
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>
+
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, or the prescribing information.<ref name="insert"></ref>
  
 
==Patient drug information==
 
==Patient drug information==
 
No information available.
 
No information available.
  
 +
==Diseases for which it is established ''(work in progress)''==
 +
*[[Malignant pleural mesothelioma]]
 +
 +
==Diseases for which it is used==
 +
*[[Colorectal cancer]]
 +
 +
==History of changes in EMA indication==
 +
*1995-11-08: EURD
 
==Also known as==
 
==Also known as==
Raltitrexed disodium, TDX, ZD 1694
+
*'''Code names:''' TDX, ZD-1694
 +
*'''Generic name:''' raltitrexed disodium
 +
*'''Brand name:''' Tomudex
  
 
==References==
 
==References==
 
<references/>
 
<references/>
  
[[Category:Drug index]]
+
[[Category:Drugs]]
[[Category:Chemotherapy]]
+
[[Category:Intravenous medications]]
[[Category:Intravenous chemotherapy]]
 
 
[[Category:Antimetabolites]]
 
[[Category:Antimetabolites]]
 
[[Category:Antifolates]]
 
[[Category:Antifolates]]
 +
 +
[[Category:Colorectal cancer medications]]
 +
[[Category:Malignant pleural mesothelioma medications]]
 +
 +
[[Category:EMA approved in 1995]]
 +
[[Category:Health Canada approved drugs]]

Latest revision as of 00:14, 6 July 2024

General information

Class/mechanism: Antimetabolite, inhibitor of thymidylate synthase. Raltitrexed is a quinazoline folate analog which inhibits thymidylate synthase (TS). TSis an enzyme involved in the synthesis of thymidine triphosphate (TTP), a nucleotide required exclusively for DNA synthesis. Inhibiting TS causes DNA damage and cell death.[1][2]
Route: IV
Extravasation: irritant

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, or the prescribing information.[1]

Patient drug information

No information available.

Diseases for which it is established (work in progress)

Diseases for which it is used

History of changes in EMA indication

  • 1995-11-08: EURD

Also known as

  • Code names: TDX, ZD-1694
  • Generic name: raltitrexed disodium
  • Brand name: Tomudex

References